US Patent Family Members and Approved Drugs for European Patent Office Patent: 0604004
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for European Patent Office Patent: EP0604004
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| ⤷ Get Started Free | 2044-05-16 | filgrastim | Amgen, Inc. | NEUPOGEN |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
